Learn More
BACKGROUND The objective of this article is to summarize the published literature concerning the pharmacokinetics and pharmacodynamics of oral anticoagulant drugs that are currently available for(More)
Oral direct inhibitors (ODIs) of thrombin and factor Xa are now approved as anticoagulant drugs. The first two drugs to complete phase III clinical trials for thromboprophylaxis in orthopaedic(More)
2012;141;e44S-e88S Chest Elaine M. Hylek and Gualtiero Palareti Walter Ageno, Alexander S. Gallus, Ann Wittkowsky, Mark Crowther, Evidence-Based Clinical Practice Guidelines ed: American College of(More)